Related Experiment Video
Updated: Dec 17, 2025

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
[Association between height loss and calcaneus bone mineral density in Chinese adults]
1Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
Insights
Height loss is linked to lower calcaneus bone mineral density (BMD), indicating a higher osteoporosis risk. Regular height checks can aid in early osteoporosis detection and prevention.
Area of Science:
- Gerontology
- Osteoporosis Research
- Bone Health
Background:
- Bone mineral density (BMD) is a key indicator of bone health and fracture risk.
- Height loss can be an indicator of underlying skeletal changes, potentially related to osteoporosis.
Purpose of the Study:
- To investigate the association between height loss and calcaneus bone mineral density (BMD) in a large Chinese cohort.
- To explore the relationship between quantitative ultrasound measures of calcaneus BMD and height changes over time.
Main Methods:
- Utilized data from 24,231 participants in the China Kadoorie Biobank (CKB) resurvey (2013-2014).
- Measured calcaneus BMD using quantitative ultrasound and calculated height loss from baseline to resurvey.
- Employed linear regression models to analyze the association between height loss and BMD measures, adjusting for confounders.
Main Results:
- A significant linear correlation was observed between height loss and calcaneus BMD (P < 0.001).
- Each 1.0 cm of height loss was associated with decreased broadband ultrasound attenuation (BUA), speed of sound (SOS), and stiffness index (SI).
- Greater height loss (≥3.0 cm) showed a more pronounced negative association with BUA, SOS, and SI. The association was stronger in females, older adults (≥55 years), and less physically active individuals.
Conclusions:
- Increased height loss is associated with reduced calcaneus bone mineral density.
- Regular height monitoring may serve as a valuable tool for the early diagnosis and prevention of osteoporosis.
Abstract:
Objective: To examine the association between height loss and calcaneus bone mineral density (BMD) through data gathered from the China Kadoorie Biobank (CKB). Methods: The present study included 24 231 participants who attended the CKB resurvey during 2013-2014, in which calcaneus BMD was measured by quantitative ultrasound method for the first time. Height loss was calculated according to the differences appeared in height measurement between baseline and resurvey. We used linear regression models to estimate the association between height loss and BMD measures. Results: The mean interval between baseline and resurvey was (8.0±0.8 ) years. 33.0% of the participants showed a height loss of ≥1.0 cm, and another 3.7% were with height loss of ≥3.0 cm. After adjustment for potential confounders, there was a linear correlation seen between height loss and BMD (P for all linear trend were <0.001). The βs (95%CIs) for each 1.0 cm of height loss were -0.79 (-0.95--0.63) for broadband ultrasound attenuation (BUA), -2.74 (-3.35--2.13) for speed of sound (SOS), and -1.29 (-1.54--1.04) for stiffness index (SI). Compared with participants with stable height, the multivariate-adjusted βs (95%CIs) for those with height loss of ≥3.0 cm were -3.29 (-4.08--2.50) for BUA, -10.70 (-13.66--7.73) for SOS, and -5.16 (-6.36--3.96) for SI, respectively. According to the subgroup analyses, the association of height loss with BMD measures seemed to be more apparent among females, in those aged ≥55 years, and those being less physically active. Conclusions: BMD became lower with the increase of height loss. Regular height measurement may contribute to the early diagnosis and prevention of osteoporosis.
More Related Videos
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling

